Raghvendra M. Srivastava

Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer

Gulidanna Shayan, Raghvendra M. Srivastava, Jing Li et al. · OncoImmunology · 2016 · 301 citations · Full text

Life Sciences, Immunology, Oncology +17

CTLA-4+ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis

Hyun-Bae Jie, Patrick J. Schuler, Steve Lee et al. · Cancer Research · 2015 · 263 citations · Full text

Life Sciences, Immunology, Oncology +17

Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients

Sumita Trivedi, Raghvendra M. Srivastava, Fernando Concha‐Benavente et al. · Clinical Cancer Research · 2016 · 131 citations · Full text

Life Sciences, Immunology, Oncology +17

Immunomodulatory effects of curcumin: In-vivo

Ch. Varalakshmi, Awais Ali, B.V.V. Pardhasaradhi et al. · International Immunopharmacology · 2008 · 125 citations

Life Sciences, Immunology, Pharmacology +10

CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer

Raghvendra M. Srivastava, Sumita Trivedi, Fernando Concha‐Benavente et al. · Clinical Cancer Research · 2016 · 124 citations · Full text

Life Sciences, Immunology, Oncology +17